第一线抗结核药物的药物遗传学:最新情况
Alessandra Manca1, Andrea Calcagno2, Antonio D'Avolio1
1Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Turin, Italy; and.
Therapeutic drug monitoring
|September 3, 2025
概括
药物遗传学通过影响个人对第一线抗生素如异化和利芬的反应来影响结核病的治疗. 了解基因变异可以个性化结核病药物治疗,
科学领域:
- 药物基因组学和精准医学
- 传染病治疗方法
背景情况:
- 结核病 (TB) 治疗需要长时间的抗生素治疗方案,包括异胺,利芬素 (RF),乙胺醇 (EMB) 和皮拉津胺.
- 药物代谢和反应的个体变化显著影响结核病治疗的疗效和毒性.
- 药物遗传学通过考虑影响药物药理动学的遗传多态性来优化结核病治疗的途径.
研究的目的:
- 审查药物遗传学对抗结核病第一线抗生素疗效和毒性的作用.
- 探索影响关键结核病药物的基因变异.
- 根据遗传特征确定针对个人结核病治疗的潜在策略.
主要方法:
- 在PubMed,Scopus,科学网络和Cochrane图书馆进行了全面的文献搜索.
- 专注于2014年12月至2024年12月出版的英语研究.
- 包括研究影响人类药物生物可用性和代谢的遗传变异.
主要成果:
- 异胺的有效性和毒性与N- 乙转移酶2 (NAT2) 基因多态性有关.
- CYP2E1,GSTM1和MnSOD的遗传变异对异酸诱导的肝毒性产生影响.
- 利芬素 (RF) 的药理动力学受SLCO1B1,ABCB1,PXR,CAR,CES1和CES2的变异影响,影响吸收,新陈代谢和清除.
- 乙胺醇 (EMB) 的生物可用性可能会因CYP1A2变异而显著降低,特别是在结核病/ 艾滋病毒共感染的情况下.
- 其他基因变异 (ABCB1,OATP1B1,PXR,VDR,CYP24A1,CYP27B1) 可能会调节EMB度和疗效.
结论:
- 将药物遗传学纳入结核病的临床实践可以提高治疗效率并尽量减少毒性.
- 基于遗传特征的个性化剂量策略对于优化结核病药物治疗至关重要.
- 需要进一步的研究和临床验证,以便在结核病治疗中常规应用药物遗传学,为精准医学铺平道路.
相关概念视频
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Nonlinear Pharmacokinetics: Role of Transporters
91
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
91
Nonlinear Pharmacokinetics: Causes of Nonlinearity
338
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
338
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Factors Affecting Drug Biotransformation: Biological
231
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
231


